Published in

Royal Society of Chemistry, Chemical Society Reviews, 6(50), p. 3647-3655, 2021

DOI: 10.1039/d0cs01118e

Links

Tools

Export citation

Search in Google Scholar

Antiviral drug discovery: preparing for the next pandemic

Journal article published in 2021 by Catherine S. Adamson ORCID, Kelly Chibale ORCID, Rebecca J. M. Goss ORCID, Marcel Jaspars, David J. Newman ORCID, Rosemary A. Dorrington ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

SARS-CoV-2, EBOV and emerging RNA viruses are amongst the most important global health threats; yet clinically approved antiviral drugs are available for only 10 of the more than 220 viruses known to infect humans.